Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9c875e830247c920c8a7159d188f28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66896af986b5ec294b29561c796396c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d570da4b9b07ea2903f58b4eaa0ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_191574523702fa9f3cd614495e01e01d |
publicationDate |
2022-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3957364-A1 |
titleOfInvention |
A binding molecule specifically binding to human cd4 for use in the treatment of pulmonary diseases |
abstract |
The present invention relates to a binding molecule specifically binding to human CD4 for use in the prevention, amelioration and/or treatment of at least symptom of a disease associated with inflammation of the respiratory tract and/or immunologically induced injury of the respiratory tract in a human subject, wherein the binding molecule is administered intranasally and/or via inhalation and/or systemically, as well as to pharmaceutical compositions, pulmonary drug delivery kits and pharmaceutical packages related thereto. |
priorityDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |